NRx Pharmaceuticals (NRXP) Appoints Stephen Willard as CEO and Director
Go back to NRx Pharmaceuticals (NRXP) Appoints Stephen Willard as CEO and Director| (NASDAQ: NRXP) | Delayed: 3.51 +0.18 (5.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.33 | 52 Week High | $ | |||
| Open | $3.36 | 52 Week Low | $ | |||
| Day High | $3.55 | P/E | N/A | |||
| Day Low | $3.33 | EPS | $ | |||
| Volume | 809,121 | |||||

